Index of medicine substances

Rosuvastatin + fenofibrate  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents (C10BA09)

Rosuvastatin + perindopril  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX21)

Rosuvastatin + perindopril + indapamide  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX13)

Rosuvastatin + valsartan  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX10)

Rotavirus vaccine  •  Antiinfectives for systemic use | Viral vaccines | Rotavirus diarrhea vaccines (J07BH01)

Rotigotine  •  Nervous system | Dopaminergic agents | Dopamine agonists (N04BC09)

Roxadustat  •  Blood and blood forming organs | Other antianemic preparations (B03XA05)

Roxithromycin  •  Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins (J01FA06)

Rozanolixizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Neonatal fragment crystallizable receptor (fcrn) inhibitors (L04AL02)

Rufinamide  •  Nervous system | Antiepileptics | Antiepileptics | Carboxamide derivatives (N03AF03)

Rupatadine  •  Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use (R06AX28)

Rurioctocog alfa pegol  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD02)

Ruscus extract + hesperidin methyl chalcone + ascorbic acid  •  Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents (C05CXN1)

Rutoside  •  Cardiovascular system | Capillary stabilizing agents | Bioflavonoids (C05CA51)

Rutoside + ascorbic acid  •  Cardiovascular system | Capillary stabilizing agents | Bioflavonoids (C05CA51)

Rutoside + bromelain + trypsin  •  Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Enzymes (M09AB52)

Ruxolitinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors (L01EJ01)